Shares of Varex Imaging (NASDAQ:VREX – Get Free Report) have been assigned a consensus rating of “Moderate Buy” from the five brokerages that are covering the company, Marketbeat reports. One research analyst has rated the stock with a sell rating, one has given a hold rating, two have issued a buy rating and one has given a strong buy rating to the company. The average 1-year price target among brokers that have updated their coverage on the stock in the last year is $16.1667.
Several analysts have commented on the stock. Wall Street Zen downgraded shares of Varex Imaging from a “buy” rating to a “hold” rating in a research report on Saturday, May 9th. Zacks Research raised shares of Varex Imaging from a “hold” rating to a “strong-buy” rating in a report on Monday, April 13th. B. Riley Financial restated a “buy” rating on shares of Varex Imaging in a report on Thursday, February 12th. Finally, Weiss Ratings restated a “sell (d-)” rating on shares of Varex Imaging in a report on Friday, March 27th.
View Our Latest Stock Analysis on Varex Imaging
Varex Imaging Stock Up 2.1%
Varex Imaging (NASDAQ:VREX – Get Free Report) last released its quarterly earnings data on Thursday, May 7th. The company reported $0.21 earnings per share for the quarter, missing the consensus estimate of $0.22 by ($0.01). The company had revenue of $216.00 million during the quarter, compared to analyst estimates of $216.92 million. Varex Imaging had a negative net margin of 9.64% and a positive return on equity of 8.19%. Varex Imaging has set its Q3 2026 guidance at 0.150-0.300 EPS. As a group, equities research analysts anticipate that Varex Imaging will post 0.93 EPS for the current year.
Insider Transactions at Varex Imaging
In other Varex Imaging news, Director Jay K. Kunkel sold 4,510 shares of the firm’s stock in a transaction on Friday, March 20th. The shares were sold at an average price of $11.14, for a total value of $50,241.40. Following the sale, the director directly owned 23,450 shares in the company, valued at $261,233. This trade represents a 16.13% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. 4.60% of the stock is owned by corporate insiders.
Institutional Investors Weigh In On Varex Imaging
A number of hedge funds have recently made changes to their positions in the company. Vanguard Group Inc. increased its position in shares of Varex Imaging by 4.4% during the 3rd quarter. Vanguard Group Inc. now owns 2,989,847 shares of the company’s stock worth $37,074,000 after purchasing an additional 126,396 shares in the last quarter. Cooke & Bieler LP increased its position in Varex Imaging by 2.2% in the 4th quarter. Cooke & Bieler LP now owns 1,632,525 shares of the company’s stock valued at $19,019,000 after acquiring an additional 35,042 shares in the last quarter. Neuberger Berman Group LLC increased its position in Varex Imaging by 1.4% in the 3rd quarter. Neuberger Berman Group LLC now owns 1,518,674 shares of the company’s stock valued at $18,810,000 after acquiring an additional 21,499 shares in the last quarter. Rice Hall James & Associates LLC increased its position in Varex Imaging by 17.7% in the 1st quarter. Rice Hall James & Associates LLC now owns 1,274,818 shares of the company’s stock valued at $13,526,000 after acquiring an additional 191,854 shares in the last quarter. Finally, LSV Asset Management increased its position in Varex Imaging by 210.7% in the 4th quarter. LSV Asset Management now owns 1,244,329 shares of the company’s stock valued at $14,496,000 after acquiring an additional 843,805 shares in the last quarter.
Varex Imaging Company Profile
Varex Imaging Corporation is a global provider of X-ray imaging components and solutions for the medical, security and industrial markets. The company designs, develops and manufactures a broad range of products that convert X-ray energy into high-resolution digital images. Its portfolio includes X-ray tubes, flat panel detectors, digital sensors, specialty radiographic tubes and related software, all engineered to meet the demanding requirements of original equipment manufacturers (OEMs) in diagnostic imaging, computed tomography (CT), fluoroscopy, mammography, dental radiography and non-destructive testing applications.
The company’s medical imaging offerings support a wide spectrum of clinical modalities, from portable radiography systems to advanced CT scanners, enhancing image quality and dose efficiency for healthcare providers.
Recommended Stories
- Five stocks we like better than Varex Imaging
- Coke’s $10B India IPO Plan Pops the Top on Hidden Value
- FedEx Unboxes Billions in Post-Spinoff Value
- Marvell’s AI Moment Raises a Bigger Question for Amazon and ServiceNow
- Palo Alto Networks Accelerates Growth 31% on AI Demand
Receive News & Ratings for Varex Imaging Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Varex Imaging and related companies with MarketBeat.com's FREE daily email newsletter.
